Azstarys
- Medicine Name: Azstarys
- Generic Name: Serdexmethylphenidate and Dexmethylphenidate
- Dosage Form & Strength: Capsules: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg
- Manufactured By: KemPharm, Inc.
Medical Uses
Azstarys specifically contain serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate. Azstarys is a central nervous system (CNS) stimulant prescription medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older. This medicine may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.
Recommended Dosage: Administer the proposed dosage orally (by mouth) once daily in the morning with or without food. Azstarys capsules may be swallowed whole or opened and the existing contents sprinkled into water (50mL) or over 2 tablespoons of applesauce. Consume all the medicine/food mixture promptly or within 10 minutes of mixing; avoid storing for future use.
Pediatric Patients 6-12 Years of Age: The recommended starting dosage of Azstarys is 39.2 mg serdexmethylphenidate/ 7.8 mg dexmethylphenidate once daily in the morning. The dosage can be increased after 1 week to a dosage of 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate per day, or decreased after one week to a dosage of 26.1 mg serdexmethylphenidate/5.2 mg dexmethylphenidate daily, on behalf of response and tolerability. The maximum recommended dosage is 52.3 mg serdexmethylphendiate/10.4 mg dexmethyphenidate once daily.
Adults and Pediatric Patients 13-17 Years of Age: The recommended starting dosage of Azstarys is 39.2 mg serdexmethylphenidate/7.8 mg dexmethylphenidate once daily in the morning. The dosage can be increased after 1 week to a dosage of 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate daily. The maximum recommended dosage is 52.3 mg serdexmethylphenidate/10.4 mg dexmethylphenidate once daily.
Pharmacological treatment of Attention Deficit Hyperactivity Disorder may be required for an extended time span. Periodically reevaluate the long-term use of this (Azstarys) treatment, and adjust dosage as required.
Warning & Precautions
- CNS stimulants, including medicine Azstarys, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Evalute the probability of abuse before prescribing, and monitor for signs/symptoms of abuse and dependence while on therapy.
- Sudden death, ainfarction and stroke may be reported in adults with CNS stimulant treatment at recommended doses. Avoid use in those with serious heart rhythm abnormalities, known structural cardiac abnormalities, cardiomyopathy, coronary artery disease, and other serious heart complications. Further assess those who develop unexplained syncope, exertional chest pain, or arrhythmias during treatment.
- CNS stimulants may cause an increase in blood pressure (mean increase around 2-4 mmHg) and heart rate (mean increase around 3-6 beats per minute). Individuals may have greater increases. Evaluate all respective patients for hypertension as well as tachycardia.
- CNS stimulants may be responsible for inducing a manic or mixed mood episode in patients. Before starting treatment, screen patients for potential for establishing a manic episode (e.g., comorbid or a family history of suicide, depression, or bipolar disorder).
- CNS stimulants for ADHD, including Azstarys, are linked with peripheral vasculopathy, including Raynaud’s phenomenon. Precise observation for digital changes is crucial during therapy with ADHD stimulants. Further clinical assessment (rheumatology referral) may be apt for certain patients.
- CNS stimulants may be responsible for weight loss and slowing of growth rate in pediatric patients. Precisely monitor growth (weight as well as height) in pediatric patients treated with CNS stimulants, including Azstarys. Those who are not growing or gaining height or weight as required may need to have their therapy interrupted.
Documentation & Availability
What documents are required to import AZSTARYS to India?
AZSTARYS (Serdexmethylphenidate and Dexmethylphenidate) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is AZSTARYS available in India?
AZSTARYS (serdexmethylphenidate and dexmethylphenidate capsule) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
AZSTARYS can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of AZSTARYS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Azstarys price in India .
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the AZSTARYS (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Azstarys®?
Serdexmethylphenidate/Dexmethylphenidate is Generic Name for the trade name drug Azstarys®.
What is the Manufacturer Name of Azstarys®?
Azstarys® is manufactured by KemPharm, Inc.
Is Azstarys® approved by the FDA?
Yes, Azstarys® is approved by the FDA. Date of approval: March 2, 2021.
What is the dosage and form of Azstarys® supplied?
Azstarys® is supplied as Capsules (serdexmethylphenidate/dexmethylphenidate): 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg for oral administration.
Where can I get Azstarys® 26.1 mg capsule at the best price in India?
To get the best azstarys 26.1 mg Capsules price in India, kindly contact S S Healthcare (a WHO GDP & ISO 9001 : 2008 certified company). For Azstarys, a valid medical prescription is required from your treating physician.
What are the most common side effects with Azstarys®?
The most common side effects with Azstarys® are: insomnia, nausea, appetite decreased, blood pressure increased, vomiting, weight decreased, dyspepsia, abdominal pain, anxiety, dizziness, irritability, affect lability, and tachycardia.
How much does Azstarys® cost in India?
The cost of Azstarys in India is less and can vary. In order to procure this ADHD medication authentically, one can Call/WhatsApp: +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Azstarys®?
Store at temperature 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F). Protect the capsules from moisture. Dispense in well tight container.
Is it safe to buy Azstarys® capsules online from India?
Yes, you can buy azstarys capsules online at best price from the S S Healthcare if Azstarys (Serdexmethylphenidate/Dexmethylphenidate) has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Azstarys®?
Click Here to download full Azstarys prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
